← Stocks · ELAB record
Signal record & history · Trifecta Signals
PMGC has been flagged by the Trifecta screener 1 time since 2025. 1 signal confirmed; the median confirmed signal is down 99.8% since its Early Signal.
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
Headline statistics: confirmed signals only, measured from the confirmation price.
First signal Sep 2025 · Latest Sep 2025 · Confirmed 1 of 1 Early · Latest close in the chart data: Thu, Nov 5, 2026
Groups are mutually exclusive — every confirmed signal sits in exactly one.
Since September 2025, PMGC has had one Early signal, one confirmed. Its one decided signal gained +10% within 90 days, and it did not finish ahead of the S&P 500 since confirmation.
Every Early signal in the record, newest first.
Members see every signal below, and the group mix above.
Membership unlocks the complete signal timeline for ELAB and every other stock in the record — group tags, caution flags, and the full screener.
Already a member? Sign in and this page unlocks.
PMGC Holdings is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. Its market value of about $1.6 million places it in the small-cap group.
PMGC Holdings’ standout Trifecta run followed a September 2025 confirmation, falling about 33% over the next 90 days. For classification, its latest signal was rated Low Quality, revenue was shrinking by about 361% at the time, and it sat in the small-cap group when that signal fired.
At the most recent close, Thursday, November 5, the shares finished at $1.65, down 14.1% on the day. Over the past week, the shares have traded in a range between about $1.65 and $2.60.
